Latest announcements

Comment on faster access for patients to cannabis-based medicinal products (CBMPs) following relaxation of import restrictions by the Department of Health and Social Care (DHSC) and the Home Office.

Yesterday the Department of Health and Social Care (DHSC) and the Home Office announced that patients will be able to get faster access to cannabis-based medicinal products (CBMPs) through the relaxation of import restrictions. Sativa welcomes this initiative as it endorses the Group’s view that the UK is fast-developing as a significant medicinal cannabis market… Read more

PRESS RELEASE: Placing and subscription to raise approximately £1.38 million

Sativa Group plc [NEX: SATI], the UK’s leading quoted CBD wellness and medicinal cannabis group, is pleased to announce that it has raised approximately £1.38 million (before expenses) by way of a placing and subscription of 34,500,000 new ordinary shares of 0.25 pence each (“New Ordinary Shares”) at a price of 4 pence per New Ordinary Share (the “Placing Price”) (the “Fundraising”).

PRESS RELEASE: Company Update (25th November 2019)

Following the appointment of Henry Lees-Buckley as Chief Executive Officer in August 2019, the Group has developed to become a UK-centric, cohesive and complementary group of five operating subsidiaries.

PRESS RELEASE: PDMR Shareholding (11th November 2019)

Sativa Group plc (NEX: SATI) has been notified that on 8 November 2019, George Thomas, MD of George Botanicals and a PDMR, completed the purchase of 500,000 ordinary shares of 0.25 pence each in the Company (“Ordinary Shares”) at an average price of 5.375p per share.